CVE-2024-27086

MSAL.NET applications targeting Xamarin Android and .NET Android (MAUI) susceptible to local denial of service

Description

The MSAL library enabled acquisition of security tokens to call protected APIs. MSAL.NET applications targeting Xamarin Android and .NET Android (e.g., MAUI) using the library from versions 4.48.0 to 4.60.0 are impacted by a low severity vulnerability. A malicious application running on a customer Android device can cause local denial of service against applications that were built using MSAL.NET for authentication on the same device (i.e., prevent the user of the legitimate application from logging in) due to incorrect activity export configuration. MSAL.NET version 4.60.1 includes the fix. As a workaround, a developer may explicitly mark the MSAL.NET activity non-exported.

Category

3.9
CVSS
Severity: Low
CVSS 3.1 •
EPSS 0.04%
Affected: AzureAD microsoft-authentication-library-for-dotnet
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2024-27086?
CVE-2024-27086 has been scored as a low severity vulnerability.
How to fix CVE-2024-27086?
To fix CVE-2024-27086, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-27086 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-27086 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-27086?
CVE-2024-27086 affects AzureAD microsoft-authentication-library-for-dotnet.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.